EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prognostic Value of Massiveness Parameters Measured on Baseline FDG PET in Advanced‐Stage Hodgkin Lymphoma

S Draye-Carbonnier iD, S-D Mihailescu, P Pinochet, E Texte, A Stamatoullas-Bastard, P Vera, S Becker, P Decazes

Cancer Medicine · 2025

DOI: 10.1002/cam4.71462 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von S Draye-Carbonnier und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Centre Henri Becquerel, Rouen, France. Hauptthemen laut MEDLINE: Hodgkin Disease, Fluorodeoxyglucose F18, Positron Emission Tomography Computed Tomography. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

The prognostic value of radiomic quantitative features measured on pretreatment 18 F‐FDG PET/CT was investigated in patients with advanced‐stage Hodgkin lymphoma (HL).

Methods

We conducted a retrospective study of 176 HL patients diagnosed between 2006 and 2017. A dozen of PET/CT‐derived features were extracted via Oncometer3D from baseline 18 F‐FDG PET/CT images. The receiver operating characteristic (ROC) curves, Kaplan–Meier method, and Cox analyses were used to assess the prognostic factors for Overall Survival (OS) and Progression‐Free Survival (PFS) censored at 5 years.

Results

Four different clusters were identified among the 12 PET parameters analyzed: activity, tumor burden, fragmentation‐massiveness, and dispersion. On ROC analyses, medEdgeD, a massiveness parameter, had the highest AUC for OS (0.72) and PFS (0.6). Patients with high baseline medEdgeD had a significantly worse PFS ( p = 0.04) and OS ( p = 0.003) in both Kaplan–Meier and Cox univariate analyses. Furthermore, medEdgeD remained statistically significant in a multivariate analysis ( p = 0.008 for OS and p = 0.014 for PFS) including various TEP and clinical parameters used in daily routine. In addition, in sub‐group analyses, a significantly worse prognosis was observed for patients with ABVD and with high baseline medEdgeD value ( p = 0.0082 for OS and p = 0.001 for PFS). Moreover, in the bulky subgroup, medEdgeD improved prognostic accuracy ( p = 0.016).

Conclusion

PET parameters describing massiveness, in particular medEdgeD, are significantly correlated with prognosis in HL patients for OS and PFS, especially when treated with ABVD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hodgkin DiseaseFluorodeoxyglucose F18Positron Emission Tomography Computed TomographyHumansMaleFemaleAdultMiddle AgedRetrospective StudiesPrognosisYoung AdultNeoplasm StagingAdolescentAgedRadiopharmaceuticalsROC CurveTumor BurdenKaplan-Meier EstimateAntineoplastic Combined Chemotherapy Protocols

Stichwörter der Autor:innen

18F‐FDG PET/CTHodgkin lymphomaoutcome predictionprognosisradiomics

Substanzen

Fluorodeoxyglucose F18Radiopharmaceuticals

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Centre Henri Becquerel, Rouen, France.
  • Department of Statistics and Clinical Research Unit, Centre Henri Becquerel, Rouen, France.
  • Department of Hematology, Centre Henri Becquerel, Rouen, France.
  • QuantIF-LITIS (EA 4108-FR CNRS 3638), Faculty of Medicine, University of Rouen, Rouen, France.

ORCID-Profile: S Draye-Carbonnier

Zitieren

APA

Draye-Carbonnier, S., Mihailescu, S. D., Pinochet, P., Texte, E., Stamatoullas-Bastard, A., Vera, P., Becker, S., & Decazes, P. (2025). Prognostic Value of Massiveness Parameters Measured on Baseline FDG PET in Advanced‐Stage Hodgkin Lymphoma. Cancer Medicine. https://doi.org/10.1002/cam4.71462

Vancouver

Draye-Carbonnier S, Mihailescu SD, Pinochet P, Texte E, Stamatoullas-Bastard A, Vera P, et al. Prognostic Value of Massiveness Parameters Measured on Baseline FDG PET in Advanced‐Stage Hodgkin Lymphoma. Cancer Medicine. 2025. doi:10.1002/cam4.71462

BibTeX
@article{DrayeCarbonnier2025,
  author = {Draye-Carbonnier, S and Mihailescu, S-D and Pinochet, P and Texte, E and Stamatoullas-Bastard, A and Vera, P and Becker, S and Decazes, P},
  title = {Prognostic Value of Massiveness Parameters Measured on Baseline FDG PET in Advanced‐Stage Hodgkin Lymphoma},
  journal = {Cancer Medicine},
  year = {2025},
  doi = {10.1002/cam4.71462}
}
Kostenlos starten →